» Articles » PMID: 1726343

Two Distinct Receptor Subtypes for Mammalian Bombesin-like Peptides

Overview
Journal Trends Neurosci
Specialty Neurology
Date 1991 Dec 1
PMID 1726343
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian bombesin-like peptides, gastrin-releasing peptide (GRP) and neuromedin B (NMB), are structurally related neuropeptides that elicit a wide spectrum of biological activities including regulation of smooth muscle contraction, stimulation of secretion, modulation of neural activity, and growth regulation. Earlier studies have shown that GRP and NMB are expressed in different regions of both the CNS and peripheral organs. Recent ligand-binding and molecular-cloning studies have revealed two pharmacologically distinct G-protein-coupled receptor subtypes for mammalian bombesin-like peptides that have different relative affinities for GRP, NMB and bombesin receptor antagonists. Similar to the peptide ligands, the two receptor subtypes are expressed in a distinct but overlapping set of CNS regions, some of which have been identified in functional studies as sites where bombesin peptides elicit defined biological responses. Delineation of these peptide ligands and receptor subtypes will be important in future studies that explore the molecular basis for the heterogeneous nature of the responses to bombesin observed in mammalian systems.

Citing Articles

Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy.

Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen Z Proc Natl Acad Sci U S A. 2023; 120(6):e2216230120.

PMID: 36724251 PMC: 9963752. DOI: 10.1073/pnas.2216230120.


Bombesin-drug conjugates in targeted therapy for small cell lung cancer.

Zhang Y, Holland E, Dinh A, Au D, Sun L Am J Cancer Res. 2022; 12(3):927-937.

PMID: 35411251 PMC: 8984889.


The gastrin-releasing peptide/bombesin system revisited by a reverse-evolutionary study considering Xenopus.

Hirooka A, Hamada M, Fujiyama D, Takanami K, Kobayashi Y, Oti T Sci Rep. 2021; 11(1):13315.

PMID: 34172791 PMC: 8233351. DOI: 10.1038/s41598-021-92528-x.


In Vitro and In Vivo SERS Biosensing for Disease Diagnosis.

Moore T, Moody A, Payne T, Sarabia G, Daniel A, Sharma B Biosensors (Basel). 2018; 8(2).

PMID: 29751641 PMC: 6022968. DOI: 10.3390/bios8020046.


The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target.

Takanami K, Sakamoto H Curr Neuropharmacol. 2014; 12(5):434-43.

PMID: 25426011 PMC: 4243033. DOI: 10.2174/1570159X12666140923201432.